Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.15B |
| 2 |
NVIDIA
NVDA
|
+$4.1B |
| 3 |
Starbucks
SBUX
|
+$3.07B |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.91B |
| 5 |
UnitedHealth
UNH
|
+$1.46B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.5B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.28B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.66B |
| 4 |
GE Aerospace
GE
|
+$1.57B |
| 5 |
PNC Financial Services
PNC
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Healthcare | 17.77% |
| 3 | Consumer Discretionary | 12.89% |
| 4 | Industrials | 11.65% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Kimco Realty
KIM
$16.3B
| $6.43M | ﹤0.01% |
302,677
| – | – |
|
|
SVCO
427
Silvaco Group
SVCO
$252M
| $6.26M | ﹤0.01% |
1,372,346
-70,170
| -5% | -$480K |
|
428
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $6.16M | ﹤0.01% |
67,203
+16,003
| +31% | +$1.47M |
|
429
SAP
SAP
$233B
| $5.94M | ﹤0.01% |
22,147
-4,198
| -16% | -$1.14M |
|
430
PLAYSTUDIOS Inc
MYPS
$69.1M
| $5.71M | ﹤0.01% |
4,500,000
| – | – |
|
431
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $5.43M | ﹤0.01% |
395,344
+132,589
| +50% | +$1.65M |
|
432
Futu Holdings
FUTU
$14.5B
| $5.33M | ﹤0.01% |
52,123
| – | – |
|
433
Loar Holdings
LOAR
$6.82B
| $4.98M | ﹤0.01% |
70,460
-285,719
| -80% | -$20.6M |
|
434
Coupang
CPNG
$28.9B
| $4.51M | ﹤0.01% |
205,731
+17
| +0% | +$395 |
|
435
ING
ING
$102B
| $4.21M | ﹤0.01% |
212,743
-11,267
| -5% | -$200K |
|
436
Service Corp International
SCI
$11.4B
| $4.18M | ﹤0.01% |
52,165
-102,749
| -66% | -$8.08M |
|
|
NVO
437
Novo Nordisk
NVO
$201B
| $3.99M | ﹤0.01% |
57,530
+9,280
| +19% | +$766K |
|
438
Nice
NICE
$5.77B
| $3.76M | ﹤0.01% |
24,364
-1,676,089
| -99% | -$268M |
|
439
ASML
ASML
$711B
| $3.5M | ﹤0.01% |
5,190
+61
| +1% | +$44.4K |
|
440
Wolverine World Wide
WWW
$1.63B
| $3.1M | ﹤0.01% |
222,866
-405,190
| -65% | -$7.4M |
|
441
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $3.06M | ﹤0.01% |
5,503
+76
| +1% | +$44.7K |
|
442
e.l.f. Beauty
ELF
$5.42B
| $3.05M | ﹤0.01% |
48,613
-10,910
| -18% | -$950K |
|
443
KB Financial Group
KB
$41.7B
| $2.69M | ﹤0.01% |
+50,414
| New | +$2.91M |
|
444
Rio Tinto
RIO
$160B
| $2.24M | ﹤0.01% |
36,721
+3,110
| +9% | +$191K |
|
445
iShares MSCI ACWI ETF
ACWI
$33.5B
| $2.23M | ﹤0.01% |
19,196
-11,752
| -38% | -$1.41M |
|
446
NatWest
NWG
$76.8B
| $2.2M | ﹤0.01% |
184,351
+84,215
| +84% | +$944K |
|
|
AVDX
447
DELISTED
AvidXchange
AVDX
| $1.4M | ﹤0.01% |
164,986
| – | – |
|
448
STMicroelectronics
STM
$48.7B
| $1.17M | ﹤0.01% |
52,892
+3,052
| +6% | +$75K |
|
449
Halliburton
HAL
$27.5B
| $419K | ﹤0.01% |
+16,521
| New | +$434K |
|
450
Cigna
CI
$73.5B
| $329K | ﹤0.01% |
+1,000
| New | +$301K |
|
Similar funds
Capital Research Global Investors's Q1 2025 Portfolio in Review
As of Q1 2025, Capital Research Global Investors held 477 positions worth $460B, down 5.4% from $486B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Capital Research Global Investors's Q1 2025 filing shows 39 new, 191 increased, 187 reduced and 21 closed positions. Its largest new stake was Charter Communications: 1,626,990 shares worth $600M. The largest sale was Apple, an estimated $5.5B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2025 buy was Charter Communications: 1,626,990 shares worth $600M.
- Capital Research Global Investors added most to Eli Lilly in Q1 2025, an estimated $4.15B increase.
- Capital Research Global Investors's biggest Q1 2025 reduction was Apple, cutting an estimated $5.5B.
- Capital Research Global Investors fully exited East-West Bancorp in Q1 2025, selling an estimated $410M.
- Capital Research Global Investors's ten largest holdings make up 31% of its $460B portfolio in Q1 2025.
- Capital Research Global Investors opened 39 new positions and closed 21 in Q1 2025.
- Capital Research Global Investors's portfolio value fell 5.4% quarter-over-quarter to $460B.
Based on Capital Research Global Investors's 13F filing for Q1 2025, filed 12 May 2025.